Group financial statement for the first nine months of 2007

 | Source: Novonesis (Novozymes A/S) Novonesis (Novozymes A/S) 

Satisfactory growth and earnings for Novozymes. Sales rose by 15% in the first
nine months, while growth in DKK was 11%. Operating profit rose by 14%
challenged by unfavorable exchange rate movements and rising raw material and
energy prices. Productivity improvements contributed to the positive
development. Net profit for the period rose by 21% including one-off items.
Novozymes is maintaining its outlook for 2007 in DKK. 

Download the whole stock exchange announcement

Attachments

2007_25_koncernregnskab q3_en.pdf
GlobeNewswire

Recommended Reading